PortfoliosLab logoPortfoliosLab logo
ORKA vs. QSI
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ORKA vs. QSI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Oruka Therapeutics, Inc (ORKA) and Quantum-Si incorporated (QSI). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ORKA achieves a 218.41% return, which is significantly higher than QSI's -35.24% return.


ORKA

1D
-1.38%
1M
13.26%
6M
181.95%
YTD
218.41%
1Y
609.63%
3Y*
93.94%
5Y*
36.46%
10Y*
-12.31%
ALL TIME*
-28.21%

QSI

1D
-1.06%
1M
-23.43%
6M
-36.96%
YTD
-35.24%
1Y
-51.21%
3Y*
-42.31%
5Y*
-40.33%
10Y*
ALL TIME*
-40.81%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$77.59M$103.90M$107.56M
$1.94M$2.39M$5.15M

ORKA vs. QSI - Yearly Performance Comparison


2026 (YTD)20252024202320222021
ORKA
Oruka Therapeutics, Inc
218.41%56.32%76.73%-28.27%10.23%-43.12%
QSI
Quantum-Si incorporated
-35.24%-59.26%34.33%9.84%-76.75%-25.40%

Correlation

The correlation between ORKA and QSI is 0.32, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.32

Correlation (3Y)
Balances recent behavior with more history.

0.26

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.26

Correlation (All Time)
Calculated using the full available price history since Jun 10, 2021

0.25

Fundamentals

Market Cap

ORKA:

$3.61B

QSI:

$140.93M

EPS

ORKA:

-$2.27

QSI:

-$0.50

PB Ratio

ORKA:

11.01

QSI:

0.77

Total Revenue (TTM)

ORKA:

$0.00

QSI:

$1.85M

Gross Profit (TTM)

ORKA:

-$71.00K

QSI:

-$3.71M

EBITDA (TTM)

ORKA:

-$125.61M

QSI:

-$104.05M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ORKA vs. QSI — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

ORKA
ORKA Risk / Return Rank: 9999
Overall Rank
ORKA Sharpe Ratio Rank: 100100
Sharpe Ratio Rank
ORKA Sortino Ratio Rank: 9999
Sortino Ratio Rank
ORKA Omega Ratio Rank: 9898
Omega Ratio Rank
ORKA Calmar Ratio Rank: 100100
Calmar Ratio Rank
ORKA Martin Ratio Rank: 100100
Martin Ratio Rank

QSI
QSI Risk / Return Rank: 2020
Overall Rank
QSI Sharpe Ratio Rank: 1818
Sharpe Ratio Rank
QSI Sortino Ratio Rank: 1919
Sortino Ratio Rank
QSI Omega Ratio Rank: 2121
Omega Ratio Rank
QSI Calmar Ratio Rank: 1717
Calmar Ratio Rank
QSI Martin Ratio Rank: 2323
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

ORKA vs. QSI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Oruka Therapeutics, Inc (ORKA) and Quantum-Si incorporated (QSI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ORKAQSIDifference
Sharpe ratioReturn per unit of total volatility

+8.46

Sortino ratioReturn per unit of downside risk

+6.36

Omega ratioGain probability vs. loss probability

1.68

0.94

+0.74

Calmar ratioReturn relative to maximum drawdown

22.00

-0.71

+22.71

Martin ratioReturn relative to average drawdown

71.65

-0.99

+72.64

ORKA vs. QSI - Sharpe Ratio Comparison

The current ORKA Sharpe Ratio is 7.88, which is higher than the QSI Sharpe Ratio of -0.57. The chart below compares the historical Sharpe Ratios of ORKA and QSI, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

ORKA vs. QSI - Drawdown Comparison

The maximum ORKA drawdown since its inception was -100.00%, roughly equal to the maximum QSI drawdown of -95.33%. Use the drawdown chart below to compare losses from any high point for ORKA and QSI.


Loading charts...

Drawdown Indicators


ORKAQSIDifference

Max Drawdown

Largest peak-to-trough decline

-100.00%

-95.33%

-4.67%

Max Drawdown (1Y)

Largest decline over 1 year

-27.99%

-73.30%

+45.31%

Max Drawdown (3Y)

Largest decline over 3 years

-77.76%

-83.63%

+5.87%

Max Drawdown (5Y)

Largest decline over 5 years

-77.76%

-93.61%

+15.85%

Max Drawdown (10Y)

Largest decline over 10 years

-98.10%

Current Drawdown

Current decline from peak

-100.00%

-94.75%

-5.25%

Average Drawdown

Average peak-to-trough decline

-93.90%

-79.63%

-14.27%

Ulcer Index

Depth and duration of drawdowns from previous peaks

8.58%

52.58%

-44.00%

Volatility

ORKA vs. QSI - Volatility Comparison

Oruka Therapeutics, Inc (ORKA) has a higher volatility of 20.74% compared to Quantum-Si incorporated (QSI) at 15.64%. This indicates that ORKA's price experiences larger fluctuations and is considered to be riskier than QSI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ORKAQSIDifference

Volatility (1M)

Calculated over the trailing 1-month period

20.74%

15.64%

+5.10%

Volatility (6M)

Calculated over the trailing 6-month period

53.50%

61.10%

-7.60%

Volatility (1Y)

Calculated over the trailing 1-year period

78.13%

91.12%

-12.99%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

72.55%

124.83%

-52.28%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

152.67%

124.16%

+28.51%

Dividends

ORKA vs. QSI - Dividend Comparison

Neither ORKA nor QSI has paid dividends to shareholders.


PositionTTM20252024
ORKA
Oruka Therapeutics, Inc
0.00%0.00%99.82%
QSI
Quantum-Si incorporated
0.00%0.00%0.00%

Financials

ORKA vs. QSI - Financials Comparison

This section allows you to compare key financial metrics between Oruka Therapeutics, Inc and Quantum-Si incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


ORKA and QSI have a correlation of 0.32, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ORKA has higher volatility (20.74%) compared to QSI (15.64%). In terms of maximum drawdown, ORKA dropped -100.00% vs QSI's -95.33%.

ORKA currently has the higher Sharpe Ratio (7.88 vs -0.57), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ORKA and QSI

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer